Topic
Stevens-Johnson syndrome and toxic epidermal necrolysis
💡 What You Need to Know
- Definition: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, life-threatening mucocutaneous reactions, most often triggered by medications.
- Spectrum: SJS involves less than 10% body surface area (BSA) skin detachment, SJS/TEN overlap involves 10-30% BSA, and TEN involves greater than 30% BSA.
- Pathophysiology: Characterized by widespread apoptosis of keratinocytes, leading to epidermal necrosis and detachment from the dermis.
- Common Triggers: Frequently caused by certain medications including antibiotics (e.g., sulfonamides), anticonvulsants (e.g., lamotrigine, carbamazepine), NSAIDs (e.g., oxicams), and allopurinol.
- Prognosis: Both conditions carry significant morbidity and mortality, with TEN having a higher mortality rate due to complications like sepsis and multi-organ failure.
🤒 Associated Symptoms
- Prodromal Phase: Often begins with non-specific flu-like symptoms such as fever, malaise, myalgia, arthralgia, sore throat, and conjunctivitis, typically 1-3 weeks after drug exposure.
- Skin Manifestations: Rapid onset of painful, erythematous macules that progress to atypical target lesions, flaccid blisters, and widespread epidermal detachment. Nikolsky's sign (skin sloughing with gentle pressure) is positive.
- Mucosal Involvement: Severe erosions and ulcerations affecting at least two mucosal sites (oral, ocular, anogenital) are hallmark features and often precede skin lesions.
- Systemic Symptoms: Patients may develop tachycardia, hypotension, severe pain, dehydration, electrolyte imbalances, acute kidney injury, and respiratory distress.
🛡 Crucial Precautions
- Early Recognition: Prompt identification of prodromal symptoms and initial skin/mucosal changes is paramount for improving outcomes.
- Immediate Drug Discontinuation: The single most critical intervention is the immediate and complete withdrawal of the suspected causative drug.
- Avoid Re-exposure: Patients must be educated to strictly avoid the identified causative drug and chemically related compounds for life.
- Genetic Screening: Consider HLA-B*1502 screening in patients of Asian descent before initiating carbamazepine to reduce SJS/TEN risk.
- Allergy Documentation: Meticulously document all drug allergies and adverse reactions in the patient's medical record to prevent future exposure.
🍽 Dietary Directions & Restrictions
- Aggressive Hydration: Crucial due to extensive fluid loss from denuded skin and mucosal surfaces; intravenous fluids are often required.
- Nutritional Support: Many patients require enteral (nasogastric or gastrostomy tube) or parenteral nutrition due to severe oral and esophageal erosions preventing oral intake.
- Soft, Bland Diet: If oral intake is tolerated, a soft, bland, non-acidic, and non-spicy diet is recommended to minimize irritation to the compromised oral mucosa.
- Avoid Irritants: Restrict foods and beverages that are hot, acidic, spicy, or have a rough texture, as these can exacerbate oral and esophageal lesions.
⚠️ Attendant Guidelines
- Sterile Environment: Manage patients in a specialized burn unit or intensive care unit with strict aseptic techniques to minimize the risk of secondary infections.
- Wound Care: Apply gentle, non-adhesive dressings to denuded skin areas, similar to burn wound management, to protect the fragile epidermis.
- Ocular Care: Frequent ophthalmologic consultation and aggressive topical lubrication, corticosteroids, or cyclosporine drops are essential to prevent corneal damage and long-term visual impairment.
- Pain Management: Implement aggressive pain control strategies, including systemic analgesics and topical anesthetics, due to the severe pain associated with skin and mucosal lesions.
- Temperature Regulation: Maintain a warm ambient temperature to prevent hypothermia, as the extensive loss of skin barrier impairs thermoregulation.
🩺 Physician's Perspective
- Diagnosis: Primarily a clinical diagnosis based on characteristic skin lesions, mucosal involvement, and rapid progression. A skin biopsy can confirm full-thickness epidermal necrosis.
- SCORTEN Score: Utilize the SCORTEN prognostic score to assess disease severity and predict mortality risk based on clinical parameters.
- Immunomodulation: Systemic corticosteroids, intravenous immunoglobulins (IVIG), or cyclosporine may be considered, but their efficacy remains controversial and timing is critical.
- Multidisciplinary Care: A collaborative approach involving dermatology, critical care, ophthalmology, nutrition, and pain management specialists is vital for comprehensive care.
- Long-term Follow-up: Essential to monitor for chronic sequelae, including ocular complications (e.g., dry eyes, symblepharon), skin scarring, dyspigmentation, and nail dystrophies.
🎓 Academic & Nursing Corner
- Comprehensive Assessment: Perform meticulous skin and mucosal assessments, monitor vital signs, and accurately chart fluid balance.
- Aseptic Wound Management: Adhere strictly to aseptic techniques during dressing changes and handle fragile skin with extreme gentleness to prevent further damage and infection.
- Oral Hygiene: Provide frequent, gentle oral care using non-irritating solutions to maintain hygiene and comfort for patients with severe oral erosions.
- Patient and Family Education: Educate patients and their families thoroughly about the condition, identified causative agents, and the critical importance of lifelong avoidance.
- Psychological Support: Offer emotional and psychological support to patients and families, addressing the significant distress caused by the disfiguring nature and severe pain of SJS/TEN.
🔬 Clinical Reference Index
- ICD-10 Codes: L51.1 (Stevens-Johnson syndrome), L51.2 (Toxic epidermal necrolysis), L51.3 (SJS/TEN overlap syndrome).
- Key Causative Drugs: Sulfonamide antibiotics, anticonvulsants (phenytoin, carbamazepine, lamotrigine), allopurinol, NSAIDs (oxicams), nevirapine.
- Histopathology: Characterized by full-thickness epidermal necrosis with sparse dermal inflammatory infiltrate and subepidermal blistering.
- Differential Diagnosis: Includes Staphylococcal scalded skin syndrome (SSSS), erythema multiforme major, generalized bullous fixed drug eruption, and acute generalized exanthematous pustulosis (AGEP).
- SCORTEN Criteria: Age >40 years, heart rate >120 bpm, presence of malignancy, BSA involved >10%, serum urea >10 mmol/L, serum glucose >14 mmol/L, serum bicarbonate <20 mmol/L.